Instrument Fundamentals
| Date | Close | Change | Change (%) | Open | High | Low |
|---|
News
Analyzing Merck & Co., Inc. (NYSE:MRK) & Lexaria Bioscience (NASDAQ:LEXX) - Markets Daily
Merck & Co., Inc. $MRK Shares Sold by Commonwealth Equity Services LLC
Merck & Co., Inc. $MRK Stock Acquired by Compass Financial Management LLC
Merck & Co., Inc. $MRK Shares Acquired by Alta Advisers Ltd
Business Development Supports Merck & Co.'s (MRK) Next Growth Chapter
Merck & Co., Inc. (NYSE:MRK) Coverage Initiated by Analysts at Argus
Merck & Co., Inc. $MRK Shares Sold by Boston Trust Walden Corp
Argus Initiates Coverage on Merck & Co., Inc. (NYSE:MRK) - Stock Observer
Merck & Co., Inc. (NYSE:MRK) Stock Rated Strong-Buy in New Coverage at Argus - Daily Political
Merck & Co., Inc. $MRK Shares Acquired by Rakuten Investment Management Inc.
15,279 Merck & Co., Inc. $MRK Shares Bought by Provenance Wealth Advisors LLC
Merck begins Phase III ENHANCE-3 trial of Ohtuvayre in COPD
First Nebraska Trust Co Makes New $14.85 Million Investment in Merck & Co., Inc. $MRK - Markets Daily
AIA Group Ltd Sells 55,326 Shares of Merck & Co., Inc. $MRK
First Nebraska Trust Co Buys 102,205 Shares of Merck & Co., Inc. $MRK - Stock Observer
Merck's Pipeline Could Be Its Next Big Growth Driver. Its Latest Earnings Offer a Clue.
Buy, Sell, or Hold? Tuesday's Top Upgrades and Downgrades: AON, Bloom Energy, Chevron, Cloudflare, Marvell Technologies, Lumentum Holdings, Merck & Co., Roku, X-Energy, and More
8,503 Merck & Co., Inc. $MRK Shares Bought by GRIMES & Co WEALTH MANAGEMENT LLC
Merck & Co., Inc. (NYSE:MRK) Stock Rating Lowered by DZ Bank - Daily Political
Merck & Co., Inc. (NYSE:MRK) Stock Gets Price Target Boost from Freedom Broker
Merck & Co., Inc. (NYSE:MRK) Stock Gets Price Target Increase from Cantor Fitzgerald
Merck & Co., Inc. $MRK Stock Position Increased by Trek Financial LLC
Merck & Co., Inc. (NYSE:MRK) Stock Price Target Raised at Cantor Fitzgerald
Merck & Co., Inc. $MRK Stock: Heritage Investors Management Corp Decreases Holdings
Merck & Co., Inc. $MRK Shares Bought by International Assets Investment Management LLC
Merck & Co., Inc. $MRK Shares Sold by Bank Julius Baer & Co. Ltd Zurich
Merck & Co., Inc. $MRK Stock Acquired by Greenleaf Trust - Stock Observer
Sumitomo Mitsui Trust Group Inc. Sells 190,066 Shares of Merck & Co., Inc. $MRK
1,793,130 Shares in Merck & Co., Inc. $MRK Bought by Mirae Asset Global Investments Co. Ltd.
Profund Advisors LLC Purchases 7,628 Shares of Merck & Co., Inc. $MRK
Merck & Co., Inc. $MRK Stock: Vise Technologies Inc. Boosts Holdings
Promising Pharmaceutical Stocks To Follow Today - October 31st - Stock Observer
Merck & Co., Inc. $MRK Stock: Raleigh Capital Management Inc. Cuts Holdings - Markets Daily
Merck & Co., Inc. $MRK Position Cut by Raleigh Capital Management Inc.
Merck & Co., Inc. $MRK Shares Acquired by Renaissance Investment Group LLC
Merck & Co., Inc. (NYSE:MRK) Given New $171.00 Price Target at Guggenheim - Zolmax
Merck & Co., Inc. (NYSE:MRK) Stock Has Average Price Target of $156.08 According to Brokerages
Merck & Co., Inc. $MRK Shares Sold by Americana Partners LLC
VIRGINIA RETIREMENT SYSTEMS ET Al Sells 222,800 Shares of Merck & Co., Inc. $MRK - Stock Observer
Merck & Co., Inc. (NYSE:MRK) Stock Price Breaks Above 50-Day Moving Average After Analyst Downgrade
Merck (NYSE: MRK) lifts sales outlook midpoint but third-quarter GAAP EPS falls 12% - Zolmax
Merck & Co., Inc. (NYSE:MRK) Stock Gets Price Target Increase from JPMorgan Chase & Co.
Merck & Co., Inc. (NYSE:MRK) Posts Quarterly Earnings Results, Beats Expectations By $0.40 EPS - Markets Daily
CMMB Celebrates New Distribution Center at the Brethren Service Center with Ribbon-Cutting Ceremony
Merck & Co., Inc. (NYSE:MRK) Stock Price Expected to Rise, Guggenheim Analyst Says
Merck & Co., Inc. Q3 Earnings Call Highlights
Merck & Co., Inc. $MRK Stake Lessened by Soltis Investment Advisors LLC
Merck & Co., Inc. (NYSE:MRK) Releases Earnings Results
Merck & Co., Inc. Q3 2026 Earnings Call Summary
Merck & Co., Inc. (MRK) Stock: Jumps 3.84% as Q3 2026 Revenue Rises 5% to $18.1 Billion
Merck Reports Q3 Revenue of $18.1 Billion, Raises 2026 Earnings Guidance
Merck 3Q Revenue Up on Keytruda, Winrevair Growth - Update | Morningstar
Merck Boosts FY26 Outlook - Update
Merck 3Q Revenue Up on Keytruda, Winrevair Growth | Morningstar
Merck & Co Inc. Q3 Income Retreats
Merck & Co Q3 26 Earnings Conference Call At 9:00 AM ET
17,813 Merck & Co., Inc. $MRK Shares Sold by D.A. Davidson & CO.
Merck & Co., Inc. $MRK Shares Sold by Convergence Financial LLC
12,469 Merck & Co., Inc. $MRK Shares Sold by Bokf Na
Health Sciences Authority of Singapore approves MSD's CAPVAXIVE pneumococcal 21-valent conjugate vaccine for prevention of invasive pneumococcal disease and pneumococcal pneumonia in adults
5-year outcomes of chemotherapy de-escalation in HER2-positive early breast cancer and exploratory circulating tumor DNA analyses from the randomized phase 2 PHERGain trial
Merck News | Markets Insider
Top Pharmaceutical Stocks To Follow Now - October 28th - Zolmax
13,296 Shares in Moderna, Inc. $MRNA Bought by Great Lakes Retirement Inc.
Merck & Co., Inc. $MRK Stock Purchased by DMC Group LLC - Markets Daily
Generali Asset Management SPA SGR Purchases 17,772 Shares of Merck & Co., Inc. $MRK - Stock Observer
Pharmaceutical Stocks To Research - October 27th - Zolmax
Moderna, Inc. (NASDAQ:MRNA) Stock Has Average Price Target of $101.45 - Markets Daily
FY2028 EPS Estimate for Moderna Cut by Analyst - Zolmax
Robeco Institutional Asset Management B.V. Makes New Investment in Moderna, Inc. $MRNA
New Indication Application for Sacituzumab Tirumotecan (sac-TMT) in Combination with Pembrolizumab as First-Line Treatment for PD-L1-Negative Non-Squamous NSCLC Accepted for Review by NMPA
Merck & Co., Inc. $MRK Position Lifted by Oppenheimer & Co. Inc.
Leo Wealth LLC Makes New Investment in Merck & Co., Inc. $MRK
23,115 Merck & Co., Inc. $MRK Shares Sold by apricus wealth LLC
Merck & Co., Inc. $MRK Stock: Oppenheimer & Co. Inc. Boosts Stake - Daily Political
FY2028 EPS Forecast for Moderna Lowered by Analyst - Daily Political
FY2030 EPS Estimate for Moderna Lowered by Analyst - Zolmax
Merck's KEYTRUDA Cuts Progression Risk By 43% In Phase 3 Endometrial Cancer Trial
Wall Street Analysts Are Bullish on Top Healthcare Picks
Barclays Issues Positive Forecast for Merck & Co., Inc. (NYSE:MRK) Stock Price
Best Healthcare Stocks To Watch Today - October 26th - Stock Observer
Merck & Co., Inc. (NYSE:MRK) Stock Gets Price Target Increase from Barclays - Stock Observer
Apollon Wealth Management LLC Purchases 46,936 Shares of Merck & Co., Inc. $MRK
Merck & Co., Inc. $MRK Holdings Lessened by Sigma Planning Corp - Daily Political
Barclays Reaffirms Their Buy Rating on Merck & Company (MRK)
Analysts Offer Insights on Healthcare Companies: ArriVent BioPharma, Inc. (AVBP) and Merck & Company (MRK)
Merck & Co., Inc. $MRK Stake Boosted by Norris Perne & French LLP MI - Markets Daily
Merck & Co., Inc. $MRK Position Trimmed by Middleton & Co. Inc. MA - Markets Daily
MerckCo News
Micron Stock Price Forecast 2026–2030: Can AI Memory Demand Reverse a 26% Week-to-Date Sell-Off?
Arm Holdings Stock Forecast 2026–2030: Can Data-Center Royalty Growth Drive a Recovery?
Boeing Stock Forecast 2026–2030: Can a Record $745 Billion Backlog Reverse BA’s 11% Earnings Sell-Off?
Latest news
Show more
Nasdaq Falls 5.52% as AI Selloff Drives S&P 500’s Worst Day Since April 2025
Nvidia Stock Falls 9.26% to $181.60 as Data Center Concerns Hit AI Shares
AppLovin Stock Soars 31% as Record Revenue and a $3.2 Billion Buyback Defy the AI Sell-Off
Oil Price Today Rebounds Toward $100 as New Tanker Attacks Revive Supply Fears
Tesla Plans Cybertruck Wind-Down in Texas as Cybercab Takes Priority
